Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Igor Andrašina"'
Autor:
Dominik Šafčák, Sylvia Dražilová, Jakub Gazda, Igor Andrašina, Svetlana Adamcová-Selčanová, Radovan Barila, Michal Mego, Marek Rác, Ľubomír Skladaný, Miroslav Žigrai, Martin Janičko, Peter Jarčuška
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3557-3570 (2023)
Hepatocellular carcinoma (HCC) has multiple molecular classes that are associated with distinct etiologies and, besides particular molecular characteristics, that also differ in clinical aspects. We aim to characterize the clinical aspects of alcohol
Externí odkaz:
https://doaj.org/article/8d822def4b264708af41d55763b3cd0b
Autor:
Dominik Safcak, Sylvia Drazilova, Jakub Gazda, Igor Andrasina, Svetlana Adamcova-Selcanova, Lea Balazova, Radovan Barila, Michal Mego, Marek Rac, Lubomir Skladany, Miroslav Zigrai, Martin Janicko, Peter Jarcuska
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 14, p 4183 (2022)
Background and Aims: Hepatocellular cancer (HCC) often occurs in geriatric patients. The aim of our study was to compare overall survival and progression-free survival between geriatric patients (>75 years) and patients younger than 75 years and to i
Externí odkaz:
https://doaj.org/article/91ab02f5672040ebabe9fc2ea178adf8
Autor:
Milada Zemanova, Marketa Cernovska, Libor Havel, Tomas Bartek, Sarka Lukesova, Jitka Jakesova, Jaroslav Vanasek, Pavel Reiterer, Juraj Kultan, Igor Andrasina, Lenka Siskova, Leona Koubkova, Jana Skrickova, Frantisek Salajka, Milos Pesek, Petr Klepetko, Juraj Beniak, Harald Fricke, Pavla Kadlecova, Roman P. Korolkiewicz, Marek Hraska, Jirina Bartunkova, Radek Spisek
Publikováno v:
Cancer Treatment and Research Communications, Vol 28, Iss , Pp 100427- (2021)
Purpose: To investigate the efficacy and safety of an active cellular immunotherapy (DCVAC/LuCa) and chemotherapy in patients with stage IV non-small cell lung cancer (NSCLC). Patients and Methods: SLU01 was a multicenter, open-label, parallel-group,
Externí odkaz:
https://doaj.org/article/df2a1c8d1d664d14ac381beb83a7255a
Autor:
Dominik Safcak, Sylvia Drazilova, Jakub Gazda, Igor Andrasina, Svetlana Adamcova-Selcanova, Radovan Barila, Michal Mego, Marek Rac, Lubomir Skladany, Miroslav Zigrai, Martin Janicko, Peter Jarcuska
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 14, p 3186 (2021)
Objective: To compare NAFLD-related HCC and other etiology-related HCC and to describe predictive factors for survival in patients with NAFLD-related HCC independent of the BCLC staging system. Methods: We performed a multicenter longitudinal retrosp
Externí odkaz:
https://doaj.org/article/dd1090ca7d5a43e8bbdf6f20d2673077
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti [Klin Onkol] 2020 Spring; Vol. 33 (5), pp. 356-361.